An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID and is used as an anticonvulsant. (From Martindale The Extra Pharmacopoeia, 31st ed)
Vigabatrin has been studied across 15 research domains including 🧘 Stress & Anxiety, 👁️ Vision & Eye, ⏳ Longevity & Aging, 🧠 Focus & Attention, 🌤️ Mood & Depression. The primary research focus is 🧘 Stress & Anxiety with 97% of studies addressing this area.
The following compounds share molecular targets with Vigabatrin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Vigabatrin is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.